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In the last decades, the synthesis of magnetic nanoparticles, in particular magnetite nanoparticles (MNPs), has 
received increased attention due to their wide range of applications in biomedicine and technology. MNPs can 
be effectively used for diagnostics and treatment of various diseases. Size, shape, charge and surface 
chemistry of NPs are fundamental characteristics that determine substantially their properties. Moreover, these 
characteristics have a big role in the processes of pharmacokinetics and pharmacodynamics. Magnetite 
nanoparticles are nontoxic, biocompatible and degradable material.  
Considering current demographic trends in the world and the nature of the dynamics of morbidity, we can expect 
that even if the average level of cancer incidence will occur more than 15 million new cases of malignant 
neoplasms in the population each year. It is obviously that the increase of cancer incidence will be occur 
substantially due to prostate cancer in men, tumors of the colon and rectum in men and women. Thus the 
problem of creating universal drug (theranostic materials) for early diagnosis and treatment of malignancy 
becomes more and more actual. 
The opportunity of application of magnetite nanoparticles in MRI and drug delivery is highly dependent on their 
sizes and magnetic characteristics. In this work we attempted to create materials based on MNPs for prostate 
cancer therapy and diagnostics. We carried out synthesis of magnetite nanoparticles with different morphology 
(cubes, rod-like, star-like and flower-like) and with average size from 10 to 50 nm. Obtained nanoparticles were 
synthesized by thermal decomposition of iron-containing precursors in high-boiling organic solvents, as well as 
the aging method in aqueous medium. All nanoparticles were characterized by different physicochemical 
methods such as: transmission electron microscopy, X-ray diffraction, thermogravimetric analysis, ICP - MS. 
Also magnetic measurements of samples were carried out. For transfer of MNPs from the organic into the 
aqueous medium and to prevent aggregation MNPs were functionalized and coated with biocompatible 
copolymers based on polyethyleneglycol and pluronic. 
 
 
Figure 1 – Mechanisms for the transfer of MNPs into aqueous medium: (a) by covalent binding to dopamine – 
PEG – COOH and (b) through hydrophobic interactions with modified Pluronic F127 
T2 and T1 - relaxivity were studied and on this basis we selected the potential candidate for theranostics. Then 
we carried out conjugation of the samples, which showed good results in MRI, with a vector specific to prostate 
cancer. Finally, we carried out experiments in vivo with given samples. More detail information about this 
experiment will be presented. 
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